Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients

European Journal of Cancer

Volumn 33, Issue 10, 1997, Pages 1627-1633

  LAstowska M ^a,c   Cotterill, S ^a   Pearson, A D J ^a   Roberts, P ^b   McGuckin, A ^a   Lewis, I ^b   Bown, N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c Institute of Paediatrics   (Poland)

Author keywords

Chromosome 17q gain; Neuroblastoma primary tumours; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA; MELPHALAN;

ADOLESCENT; ADULT; AGE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIPLOIDY; DNA HYBRIDIZATION; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; TETRAPLOIDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; SURVIVAL RATE;

EID: 0031409099     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00282-7     Document Type: Article

References (26)

1. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the International Criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11, 1466-1477.
2. Gugliemi M, De Bernardi B, Rizzo A, et al. Resection of primary tumor in stage IV-S neuroblastoma: does it affect the clinical course? J Clin Oncol 1996, 14, 1537-1544.
3. Christiansen H, Sahin K, Berthold F, et al. Comparison of DNA aneuoloidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma. Eur J Cancer 1995, 31A, 541-544
4. Caron H, van Sluis P, van Roy N, et al. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 1994, 55, 341-347.
5. Van Roy N, Laureys G, Ching Cheng N, et al. 1;17 translocations in human primary neuroblastoma tumors and cell lines. Genes Chromosome Cancer 1994, 10, 103-114.
6. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma. Med Ped Oncol 1995, 24, 215-221.
7. Plantaz D, Mohapatra G, Matthay KK, et al. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 1997, 150, 81-89.
8. Lastowska M, Nacheva E, McGuckin A, et al. Comparative genomic hybridization study of primary neuroblastoma tumours. Genes Chromosome Cancer 1997, 18, 162-169.
9. Lastowska M, Roberts P, Pearson ADJ, et al. Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosome Cancer 1997, 19, 143-149.
10. Meddeb M, Danglot G, Chudoba I, et al. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Genes Chromosome Cancer 1996, 17, 156-165.
11. Bown NP, Reid MM, Malcolm AJ, et al. Cytogenetic abnormalities of small round cell tumours. Med Pediatr Oncol 1994, 23, 124-129.
12. ISCN Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature, Mitelman, F, ed. S. Karger, Basel, 1995.
13. Kallioniemi OP, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumours. Genes Chromosome Cancer 1994, 10, 231-243.
14. Nacheva E, Grace C, Holloway TL, Green AR. Comparative genomic hybridization in acute myeloid leukaemia; comparison with G-banding and chromosome painting. Cancer Genet Cytogenet 1995, 82, 9-16.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
16. Cox DR, Oakes D. Analysis of Survival Data London, Chapman and Hall, 1984.
17. Gilbert F, Feder M, Balaban G, et al. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 1984, 44, 5444-5449.
18. Savelyeva L, Corvi R, Schwab M. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 1994, 55, 334-340.
19. Van Roy N, Cheng NC, Laureys G, et al. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur J Cancer 1995, 4, 530-535.
20. Schleiermacher G, Peter M, Michon J, et al. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosome Cancer 1994, 10, 275-281.
21. Takeda O, Homma C, Maseki N, et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosome Cancer 1994, 10, 30-39.
22. Rahman N, Arbour L, Tonin P, et al. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-21. Nature Genet 1996, 13, 461-463.
23. Giarnieri E, Alderisio M, Valli C, et al. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer. Anticancer Res 1995, 15, 2049-2053.
24. Leone A, Seeger RC, Hong CM, et al. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993, 8, 855-865.
25. Mertens F, Johansson B, Mitelman F. Isochromosomes in neoplasia. Genes Chromosome Cancer 1994, 10, 221-230.
26. Raimondi SC, Pui CH, Hancock ML, et al. Heterogeneity of hyperdiploid (51-57) childhood acute lymphoblastic leukemia. Leukemia 1996, 10, 213-224.